(Q34761872)

English

Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Europe PubMed Central

Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Borrelia burgdorferi

0 references

0 references

2

object named as

Peter Kraiczy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Klaus-Peter Hunfeld

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Elena Kekoukh

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Volker Schäfer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Volker Brade

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 June 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

International Journal of Medical Microbiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

291 Suppl 33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

125-137

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lyme disease assay which detects killed Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftriaxone as effective therapy in refractory Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility testing of Borrelia burgdorferi by a dialysis culture method.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of the everninomicin SCH 27899 and other newer antimicrobial agents against Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial susceptibility of Ehrlichia phagocytophila

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ketolide ABT-773 is active against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment resistant Lyme arthritis caused by Borrelia garinii

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New Chemotherapeutic Approaches in the Treatment of Lyme Borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular localization of Borrelia burgdorferi within human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost-of-illness study of Lyme disease in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of agents for use in medium for selective isolation of Lyme disease and relapsing fever Borrelia species

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo susceptibility of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Culture ofBorrelia burgdorferi on six solid media

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inactivation of diaminopyrimidines and sulfonamides in Barbour-Stoenner-Kelly medium for isolation of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotics and increased temperature against Borrelia burgdorferi in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of trimethoprim against Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lyme disease: a review of aspects of its immunology and immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Esterases in serum-containing growth media counteract chloramphenicol acetyltransferase activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of the Early Manifestations of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dialysis culture for determination of MIC and MBC of benzylpenicillin against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Lyme disease vaccine: conception, development, and implementation

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Erve virus: possible mode of transmission and reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Underreporting of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1438-4221%2802%2980024-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1438-4221(02)80024-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141737%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34761872&oldid=1417533697"